Original Communications| Volume 127, ISSUE 2, P161-169, February 2000

Adenosine prevents activation of transcription factor NF-κB and enhances activator protein-1 binding activity in ischemic rat heart


      Background: Adenosine prevents myocardial TNF-α production induced by ischemia/reperfusion, but the mechanisms are poorly understood. Transcription factors NF-κB and AP-1 have been implicated in the regulation of a variety of inducible gene expressions in response to oxidative stress and cellular defense. The effects of adenosine on NF-κB and AP-1 activation have not been clearly defined. This study demonstrated differential effects of adenosine on NF-κB and AP-1 nuclear binding activity in ischemic myocardium. Methods: Isolated working rat hearts were subjected to 0, 1, 2, 3, 4, 5, 7.5, 10, 15, and 30 minutes of ischemia, with 4 to 6 hearts for each time point with and without adenosine (100 μmol/L). NF-κB and AP-1 binding activity in the nucleus were analyzed by electrophoretic mobility shift assay (EMSA). IκBα levels in the cytoplasm were measured by Western blot analysis. TNF-α mRNA levels were determined by RT-PCR. Results: NF-κB binding activity in the nucleus significantly increased after 4 minutes of ischemia and remained to 30 minutes. The levels of IκBα protein in the cytoplasm markedly decreased after 4, 5, 7.5, and 10 minutes of ischemia. TNF-α mRNA levels peaked after 10 minutes of ischemia. AP-1 DNA binding activity was induced and persisted during all ischemic periods. Adenosine significantly inhibited NF-κB binding activity in the nucleus, markedly prevented the loss of IκBα proteins from the cytoplasm, and concomitantly down-regulated TNF-α mRNA expression, but enhanced AP-1 binding activity in the nucleus of ischemic myocardium. Conclusions: Adenosine modulation of NF-κB activation may be the cellular molecular mechanism of down-regulation of TNF-α mRNA expression. The cardioprotective properties of adenosine may be involved in the differential modulation of NF-κB and AP-1 activation during myocardial ischemia. (Surgery 2000;127:161-9.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bozkurt B
        • Kribbs SB
        • Clubb Jr, FJ
        • Michael LH
        • Didenko VV
        • Hormsby PJ
        • et al.
        Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats.
        Circulation. 1998; 97: 1382-1391
        • Kubota T
        • McTiernan CF
        • Frye CS
        • Slawson SE
        • Lemster BH
        • Koretsky AP
        • et al.
        Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.
        Circ Res. 1997; 81: 627-635
        • Kubota T
        • McTiernan CF
        • Frye CS
        • Demetris AJ
        • Feldman AM
        Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice.
        J Card Fail. 1997; 3: 117-124
        • Bryant D
        • Becker L
        • Richardson J
        • Shelton J
        • Franco F
        • Peshock R
        • et al.
        Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.
        Circulation. 1998; 97: 1375-1381
        • Meldrum DR
        • Cain BS
        • Cleveland JC
        • Meng X
        • Ayala A
        • Harken AH
        Adenosine decreases post-ischemic myocardial TNFα anti-inflammatory implications for preconditioning and transplantation.
        Immunology. 1997; 92: 472-477
        • Cain BS
        • Meldrum DR
        • Dinarello CA
        • Meng X
        • Banerjee A
        • Harken AH
        Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion.
        J Surg Res. 1998; 76: 117-123
        • Parmely MJ
        • Zhou WW
        • Edwards III, CK
        • Borcherding DR
        • Silverstein R
        • Morrison DC
        Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge.
        J Immunol. 1993; 151: 389-396
        • Hasko G
        • Szabo C
        • Nemeth NH
        • Kvetan V
        • Pastores SM
        • Vizi ES
        Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
        J Immunol. 1996; 157: 4634-4640
        • Bowlin TL
        • Borcherding DR
        • Edwards III, CK
        • McWhinney CD
        Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.
        Cell Mol Biol. 1997; 43: 345-349
        • Ritchie PK
        • Spangelo BL
        • Krzymowski DK
        • Rossiter TB
        • Kurth E
        • Judd AM
        Adenosine increases interleukin 6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages.
        Cytokine. 1997; 9: 187-198
        • Wagner DR
        • Combes A
        • McTiernan C
        • Sanders VJ
        • Lemster B
        • Feldman AM
        Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha.
        Circ Res. 1998; 82: 47-56
        • Baeuerle PA
        • Baltimore D
        NF-κB: ten years after.
        Cell. 1996; 87: 13-20
        • Baldwin Jr, AS
        The NF-κB and IκB proteins: new discoveries and insights.
        Annu Rev Immunol. 1996; 14: 649-683
        • Angel P
        • Karin M
        The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
        Biochim Biophys Acta. 1991; 1072: 129-157
        • Schreck R
        • Albermann K
        • Baeuerle PA
        Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells.
        Free Rad Res Comms. 1992; 17: 221-237
        • Devary Y
        • Gottlieb RA
        • Lau LF
        Rapid and preferential activation of the c-jun gene during the mammalian UV response.
        Mol Cell Biol. 1991; 11: 2804-2811
        • Meyer M
        • Schreck R
        • Baeuerle P
        Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor.
        EMBO J. 1993; 12: 2005-2015
        • Li C
        • Browder W
        • Kao RL
        Early activation of transcription factor NF-κB during ischemia in perfused rat heart.
        Am J Physiol. 1999; 276: H543-H552
        • Brand T
        • Sharma HS
        • Fleischmann KE
        • Duncker DJ
        • McFalls EO
        • Verdouw PD
        • et al.
        Protooncogene expression I porcine myocardium subjected to ischemia and reperfusion.
        Circ Res. 1992; 71: 1351-1360
        • Das DK
        • Moraru II
        • Maulik N
        • Engelman RM
        Gene expression during myocardial adaptation to ischemia and reperfusion.
        Ann NY Acad Sci. 1994; 723: 292-307
        • Chandrasekar B
        • Freeman GL
        Induction of nuclear factor κB and activation protein 1 in postischemic myocardium.
        FEBS Lett. 1997; 401: 30-34
        • Kao RL
        • Conti VR
        • Williams EH
        Effect of temperature during potassium arrest on myocardial metabolism and function.
        J Thorac Cardiovasc Surg. 1982; 84: 243-249
        • Dunn JA
        • Li C
        • Ha T
        • Kao RL
        • Browder W
        Therapeutic modification of nuclear factor κB binding activity and tumor necrosis factor-α gene expression during acute biliary pancreatitis.
        Am Surg. 1997; 63: 1036-1044
        • Williams DL
        • Ha T
        • Li C
        • Kalbfleisch JH
        • Laffan JJ
        • Ferguson DA
        Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3) β–D-glucan increases long-term survival in polymicrobial sepsis.
        Surgery. 1999; 126: 54-65
        • Bouma MG
        • Stad RK
        • Van den Wildenberg FAKM
        • Buurman WA
        Differential regulatory effects of adenosine on cytokine release by activated human monocytes.
        J Immunol. 1994; 153: 4159-4168
        • Reinstein LJ
        • Lichtman SN
        • Currin BT
        • Wang J
        • Thurman RG
        • Lemasters JJ
        Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells.
        Hepatology. 1994; 19: 1445-1452
        • Bouma MG
        • vanden Wildenberg FAJM
        • Buurman WA
        Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells.
        Am J Physiol. 1996; 270: C522-C529
        • Kacimi R
        • Karliner JS
        • Koudssi F
        • Long CS
        Expression and regulation of adhesion molecules in cardiac cells by cytokines, response to acute hypoxia.
        Circ Res. 1998; 82: 576-586
        • Morishita R
        • Sugimoto T
        • Aoki M
        • Kida I
        • Tomita N
        • Moriguchi A
        • et al.
        In vivo transcription of cis element “decoy” against nuclear factor-kappa B binding site prevents myocardial infarction.
        Nat Med. 1997; 3: 894-899
        • Sawa Y
        • Morishita R
        • Suzuki K
        • Kagisaki K
        • Kaneda Y
        • Maeda K
        • et al.
        A novel strategy for myocardial protection using in vivo transfection of cis element ‘decoy' against NF-κB binding site: evidence for a role of NF-κB in ischemia-reperfusion injury.
        Circulation. 1997; 96: II-280-II-285
        • Chandrasekar B
        • Etreitman JE
        • Colston JT
        • Freeman GL
        Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium.
        Biochim Biophys Acta. 1998; 1406: 91-106
        • Herskowitz A
        • Choi S
        • Ansari AA
        • Wesselingh S
        Cytokine mRNA expression in postischemic/reperfusion myocardium.
        Am J Pathol. 1995; 146: 419-428
        • Shames BD
        • Meng X
        • Barton H
        • Medrum DR
        • Pulido EJ
        • Cain BS
        • et al.
        Myocardial ischemia before reperfusion activates cardiocyte nuclear factor kappa B and induces production of tumor necrosis factor alpha.
        Surg Forum. 1998; : 231-233
        • Le Bail O
        • Schmidt-UIIrich R
        • Israël A
        Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family.
        EMBO J. 1993; 12: 5043-5049
        • Chiao PJ
        • Miyamoto S
        • Verma IM
        Autoregulation of IκBα activity.
        Proc Natl Acad Sci USA. 1994; 91: 28-32
        • Yao KS
        • Xanthoudakis S
        • Curran T
        • O'Dwyer PJ
        Activation of AP-1 and of nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.
        Mol Cell Biol. 1994; 14: 5997-6003
        • Rupec RA
        • Baeuerle PA
        The genomic response of tumor cells to hypoxia and reoxygenation differential activation of transcription factors AP-1 and NF-κB.
        Eur J Biochem. 1995; 234: 632-640
        • Choi HS
        • Moore DD
        Induction of c-fos and c-jun gene expression by phenolic antioxidants.
        Mol Endocrinol. 1993; 7: 1596-1602
        • Peng M
        • Huang L
        • Xiu ZJ
        • Huang WH
        • Askari A
        Oxidantinduced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes.
        Cell Mol Biol Res. 1995; 41: 189-197
        • Ely SW
        • Berne RM
        Protective effects of adenosine in myocardial ischemia.
        Circulation. 1992; 85: 893-904
        • Cronstein BN
        Adenosine, an endogenous anti-inflammatory agent.
        J Appl Physiol. 1994; 76: 5-13
        • Schenk H
        • Klein M
        • Erdbrügger W
        • Dröge W
        • Schulze-Osthoff K
        Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1.
        Proc Natl Acad Sci USA. 1994; 91: 1672-1676
        • Sajjadi FG
        • Takabayashi K
        • Foster AC
        • Domingo RC
        • Firestein GS
        Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors.
        J Immunol. 1996; 156: 3435-3442
        • Roberts JL
        • Messerschmidt HW
        • Kao RL
        The role of adenosine in cardioplegia.
        in: Cardioplegia: Current Concepts and Controversies. TX: RG Landers, Austin1993: 42-51